Craft

Selvita Croatia

Revenue

€30.5 M

FY, 2024

Selvita Croatia Summary

Company Summary

Overview
Selvita Croatia is a company that offers preclinical contract research services. It provides antibody drug discovery, assay development and screening, toxicology, translational research solutions, etc. The company specializes in oncology, infectious diseases, inflammation, fibrosis, neuroscience, and other areas.
Type
Subsidiary
Status
Active
Founded
2003
HQ
Zagreb, HR | view all locations
Sectors

Key People

  • Adrijana Vinter

    Adrijana Vinter, Global Head of Drug Discovery and Management Board Member

  • Marija Gradečak Galović

    Marija Gradečak Galović, Senior Director, Finance

  • Snjezana Vitez

    Snjezana Vitez, Operations Director

  • Dubravko Jelić

    Dubravko Jelić, Project Director, Integrated Drug Discovery (IDD) Pharmacology

LocationsView all

2 locations detected

  • Zagreb, Grad Zagreb HQ

    Croatia

    Prilaz Baruna Filipovića 29

  • Zagreb, Grad Zagreb

    Croatia

    Hondlova 2

Selvita Croatia Financials

Summary Financials

Revenue (FY, 2024)
€30.5M
Gross profit (FY, 2024)
€12.3M
Net income (FY, 2024)
€783.0K
Cash (FY, 2024)
€817.0K

Footer menu